doi.org/10.1200/JCO.2014.59.5058, hdl.handle.net/1765/87013
Journal of Clinical Oncology
Erasmus MC Cancer Institute

Foekens, J., Martens, J. W. M., & Sleijfer, S. (2015). Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2 - Positive breast cancer?. Journal of Clinical Oncology, 33(7), 673–675. doi:10.1200/JCO.2014.59.5058